메뉴 건너뛰기




Volumn 6, Issue 3, 2002, Pages 214-218

Concomitant basiliximab with low-dose calcineurin inhibitors in children post-liver transplantation

Author keywords

Acute cellular rejection; Basiliximab; CNI drugs; Nephrotoxicity; Paediatric liver transplantation

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CISPLATIN; CYCLOSPORIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RIBAVIRIN; TACROLIMUS; VANCOMYCIN; BASILIXIMAB; CALCINEURIN; HYBRID PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY;

EID: 0036022210     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2002.01076.x     Document Type: Article
Times cited : (26)

References (29)
  • 1
    • 0027994850 scopus 로고
    • A comparison of tacrolimus (FK 506) and cyclosporin for immunosuppression in liver transplantation
    • (1994) N Engl J Med , vol.331 , pp. 1110-1115
  • 2
    • 0029163066 scopus 로고
    • Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporin-based regimen: A controlled prospective randomised trial
    • (1995) Clin Transpl , vol.9 , pp. 406-414
    • Jonas, S.1    Kling, N.2    Bechstein, W.O.3
  • 26
    • 0031586439 scopus 로고    scopus 로고
    • Randomised trial of basiliximab versus placebo for the control of acute cellular rejection in renal allograft recipients
    • CHIB 201 International D study group
    • (1997) Lancet , vol.350 , pp. 1484
    • Nashan, B.1    Moore, R.2    Amlot, P.3
  • 27
    • 0033608073 scopus 로고    scopus 로고
    • Reduction of the episodes of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin 2 receptor monoclonal antibody
    • (1999) Transplantation , vol.67 , pp. 000-000
    • Kahan, B.D.1    Rajagopalan, P.R.2    Hall, M.3
  • 28
    • 0034330362 scopus 로고    scopus 로고
    • Prospective validation of renal function-based carboplatin dosing in children with cancer: A United Kingdom Children's Cancer Study Group Trial
    • (2000) J Clin Oncol , vol.18 , pp. 3614-3621
    • Thomas, H.1    Boddy, A.V.2    English, M.W.3
  • 29
    • 0034649068 scopus 로고    scopus 로고
    • Interleukin-2 receptor antibody induced alteration of cyclosporin dose requirements in paediatric transplant recipients
    • (2000) Lancet , vol.356 , pp. 1327-1328
    • Strehlau, J.1    Pape, L.2    Offner, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.